{"id":"https://openalex.org/W2071237954","doi":"https://doi.org/10.1185/03007990902739669","title":"Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*","display_name":"Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-29","ids":{"openalex":"https://openalex.org/W2071237954","doi":"https://doi.org/10.1185/03007990902739669","mag":"2071237954","pmid":"https://pubmed.ncbi.nlm.nih.gov/19196223"},"language":"en","primary_location":{"id":"doi:10.1185/03007990902739669","doi":"https://doi.org/10.1185/03007990902739669","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990902739669","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2071237954"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Stephen Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801184099","display_name":"James Cook University Hospital","ror":"https://ror.org/02vqh3346","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801184099","https://openalex.org/I286970279"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stephen Jones","raw_affiliation_strings":["The Academic Centre, James Cook University Hospital, Middlesbrough, UK. stephen.jones@stees.nhs.uk","The Academic Centre, James Cook University Hospital, Middlesbrough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Academic Centre, James Cook University Hospital, Middlesbrough, UK. stephen.jones@stees.nhs.uk","institution_ids":["https://openalex.org/I2801184099"]},{"raw_affiliation_string":"The Academic Centre, James Cook University Hospital, Middlesbrough, UK","institution_ids":["https://openalex.org/I2801184099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113435233","display_name":"Marian Benroubi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164705","display_name":"Polyclinic General Hospital","ror":"https://ror.org/0504y0m80","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210164705"]}],"countries":["GR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marian Benroubi","raw_affiliation_strings":["Department of Diabetes, Polyclinic General Hospital, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes, Polyclinic General Hospital, Athens, Greece","institution_ids":["https://openalex.org/I4210164705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010816868","display_name":"Conxa Castell","orcid":"https://orcid.org/0000-0003-2558-1959","observed_orcids":["https://orcid.org/0000-0003-2558-1959"]},"institutions":[{"id":"https://openalex.org/I157913058","display_name":"Generalitat de Catalunya","ror":"https://ror.org/01bg62x04","country_code":"ES","type":"government","lineage":["https://openalex.org/I157913058"]},{"id":"https://openalex.org/I4210095713","display_name":"Departament de Salut","ror":"https://ror.org/00nyrjc53","country_code":"ES","type":"government","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210095713"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Conxa Castell","raw_affiliation_strings":["Department de Salut, Generalitat de Catalunya, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department de Salut, Generalitat de Catalunya, Barcelona, Spain","institution_ids":["https://openalex.org/I157913058","https://openalex.org/I4210095713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031367602","display_name":"Albert Goday","orcid":"https://orcid.org/0000-0001-7356-1595","observed_orcids":["https://orcid.org/0000-0001-7356-1595"]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Albert Goday","raw_affiliation_strings":["Servicio de Endocrinolog\u00eda, Hospital del Mar, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Endocrinolog\u00eda, Hospital del Mar, Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101780968","display_name":"Andreas Liebl","orcid":"https://orcid.org/0000-0003-3223-535X","observed_orcids":["https://orcid.org/0000-0003-3223-535X","https://orcid.org/0000-0002-6911-4298"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andreas Liebl","raw_affiliation_strings":["Center for Diabetes and Metabolism, Fachklinik Bad Heilbrunn, Bad Heilbrunn, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Diabetes and Metabolism, Fachklinik Bad Heilbrunn, Bad Heilbrunn, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001088637","display_name":"Louise Timlin","orcid":"https://orcid.org/0000-0003-2485-4548","observed_orcids":["https://orcid.org/0000-0003-2485-4548"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Louise Timlin","raw_affiliation_strings":["Lilly Research Centre, Windlesham, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Centre, Windlesham, Surrey, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029763402","display_name":"Claudia Nicolay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudia Nicolay","raw_affiliation_strings":["Eli Lilly, European Medical, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly, European Medical, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alexander Simpson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander Simpson","raw_affiliation_strings":["Lilly Research Centre, Windlesham, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Centre, Windlesham, Surrey, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074943483","display_name":"Aod\u00e1n Tynan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aodan Tynan","raw_affiliation_strings":["Lilly Research Centre, Windlesham, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Centre, Windlesham, Surrey, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2801184099"],"apc_list":null,"apc_paid":null,"fwci":3.6076,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.93043131,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"25","issue":"3","first_page":"691","last_page":"700"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/insulin-initiation","display_name":"insulin initiation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/baseline-characteristics","display_name":"baseline characteristics","score":0.6890000104904175},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.906000018119812},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9860000014305115},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8820000290870667},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.7149999737739563},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.7450000047683716},{"id":"https://openalex.org/keywords/macrovascular-complications","display_name":"macrovascular complications","score":0.9070000052452087},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.8960000276565552},{"id":"https://openalex.org/keywords/cross-national-variation","display_name":"cross-national variation","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9588123559951782},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7406870126724243},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7040669322013855},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6973074674606323},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.6366227269172668},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5038217902183533},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4719872772693634},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.46052441000938416},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4207859933376312},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3344533443450928}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007990902739669","doi":"https://doi.org/10.1185/03007990902739669","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990902739669","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:19196223","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19196223","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W15769231","https://openalex.org/W1972329582","https://openalex.org/W1981152283","https://openalex.org/W1996441843","https://openalex.org/W1999043346","https://openalex.org/W2078806330","https://openalex.org/W2079833621","https://openalex.org/W2112679189","https://openalex.org/W2119152082","https://openalex.org/W2123946565","https://openalex.org/W2138707894","https://openalex.org/W2147079839","https://openalex.org/W2153442840","https://openalex.org/W2157209141","https://openalex.org/W2157606430","https://openalex.org/W2163678769","https://openalex.org/W2165698647","https://openalex.org/W2168893898","https://openalex.org/W2337454357","https://openalex.org/W2599408064","https://openalex.org/W2752336761","https://openalex.org/W3109617681","https://openalex.org/W3198570063","https://openalex.org/W4205288846"],"related_works":["https://openalex.org/W2033733459","https://openalex.org/W7171606264","https://openalex.org/W2164827808","https://openalex.org/W2906618818","https://openalex.org/W2996093709","https://openalex.org/W2963706556","https://openalex.org/W4231534543","https://openalex.org/W7220227132","https://openalex.org/W1984043217","https://openalex.org/W7097223583"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"describe":[2],"the":[3,76,83,120,170],"characteristics":[4],"at":[5],"baseline":[6],"of":[7,28,40,47,66,97,129,150,164,209,233],"patients":[8,29,49,67,152],"with":[9,30,52],"type":[10,31],"2":[11,32],"diabetes":[12,33],"mellitus":[13],"who":[14,34],"are":[15],"initiating":[16,36,168],"insulin.":[17],"METHODS:":[18],"Prospective,":[19],"observational":[20],"multi-centre,":[21],"open-label":[22],"study":[23],"in":[24,82,89,140,153,204,226],"five":[25],"European":[26],"countries":[27,105,142],"were":[35,50,68,122,202,221],"insulin":[37],"as":[38,116],"part":[39],"their":[41],"usual":[42],"care.":[43],"RESULTS:":[44],"A":[45],"total":[46],"1172":[48],"enrolled,":[51],"mean":[53,173],"age":[54],"63.3":[55],"years":[56],"and":[57,92,110,118,132,145,188,197,199,207],"body":[58],"mass":[59],"index":[60],"29.9":[61],"kg/m(2).":[62],"The":[63,95,148],"majority":[64,149],"(90%)":[65],"taking":[69,79],"one":[70],"or":[71],"more":[72],"oral":[73],"anti-diabetic":[74,80],"agents;":[75],"percentage":[77],"not":[78],"medication":[81],"previous":[84],"four":[85],"weeks":[86],"was":[87,136,176,183,215],"highest":[88],"Germany":[90],"(23.4%)":[91],"Spain":[93],"(15.1%).":[94],"prevalence":[96],"microvascular":[98],"diseases":[99],"(range:":[100],"16.1%-36.1%)":[101],"varied":[102],"considerably":[103,222],"between":[104],"but":[106],"for":[107,195,229],"macrovascular":[108],"(30.4%-38.6%)":[109],"other":[111,141],"diabetes-related":[112],"diagnoses":[113],"(72.6%-76.6%)":[114],"such":[115],"hypertension":[117],"dyslipidaemia":[119],"differences":[121],"less":[123,138],"pronounced.":[124],"In":[125],"Germany,":[126],"reported":[127],"use":[128],"lipid-lowering":[130],"(26.7%)":[131],"anti-platelet":[133],"(27.1%)":[134],"therapies":[135],"much":[137],"than":[139,224],"(ranges:":[143],"53.2%-78.1%":[144],"48.3%-61.1%,":[146],"respectively).":[147],"evaluable":[151],"each":[154],"country":[155],"had":[156,190],"demonstrated":[157],"poor":[158],"control":[159],"over":[160],"a":[161,230],"long":[162],"period":[163,232],"time.":[165,234],"Prior":[166],"to":[167],"insulin,":[169],"most":[171],"recent":[172],"(+/-SD)":[174],"HbA1(c)":[175,219],"9.58":[177],"+/-":[178,185],"1.81%,":[179],"fasting":[180],"plasma":[181],"glucose":[182],"12.18":[184],"4.32":[186],"mmol/L":[187],"78.5%":[189],"metabolic":[191],"syndrome.":[192],"IDF":[193],"targets":[194],"HDL-":[196],"LDL-cholesterol,":[198],"blood":[200],"pressure":[201],"met":[203],"76.8%,":[205],"33.1%":[206],"18.9%":[208],"patients,":[210],"respectively.":[211],"CONCLUSIONS:":[212],"Insulin":[213],"treatment":[214,227],"only":[216],"initiated":[217],"after":[218],"values":[220],"higher":[223],"recommended":[225],"guidelines":[228],"sustained":[231]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2071237954","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
